2) human thrombopoietin
人血小板生成素
1.
The cloning and expression of human thrombopoietin cDNA in COS7 cells;
人血小板生成素cDNA的克隆及在COS-7细胞中的表达
3) SCF-TPO fusion protein
人干细胞因子/血小板生成素融合蛋白
1.
Purification and renaturation of recombinant human SCF-TPO fusion protein;
重组人干细胞因子/血小板生成素融合蛋白的纯化及复性研究
4) recombinant human thrombopoietin
重组人血小板生成因子
1.
Phase I clinical pharmacokinetics of recombinant human thrombopoietin in healthy volunteers;
重组人血小板生成因子注射液的I期临床药代动力学
5) recombinant human thrombopoietin (rhTPO)
重组人血小板生成因子
1.
Recombinant human thrombopoietin (rhTPO) is a full-length glycosylated molecule produced in a genetically modified mammalian cell line and purified by standard technique by our Chinese boffin, National First new drug.
目的: 血小板生成素(Thrombopoietin,TPO)是近年来新发现的一种造血生长因子,重组人血小板生成因子注射液(Recombinan human thrombopoietin,rhTPO)是我国科技工作者采用重组DNA技术经提纯而制成的全长糖基化人TPO重组蛋白,属于生物制品1类新药。
6) recombinant human thrombopoietin
重组人血小板生成素
1.
Pharmacological and clinical evaluation for recombinant human thrombopoietin;
重组人血小板生成素的药理作用和临床评价
2.
Pharmacokinetics after subcutaneous multi-dosing of recombinant human thrombopoietin in patients with thrombocytopenia;
血小板减少患者多次皮下注射重组人血小板生成素的药代动力学研究
3.
Clinical observation on recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in solid tumor patients
重组人血小板生成素治疗实体肿瘤患者化疗后血小板减少的临床观察
补充资料:血小板生成
血小板生成
指血小板的发生过程。它们由骨髓巨核细胞形成,原巨核细胞经幼巨核细胞发育生成巨核细胞,其胞体很大(直径约40~ 70μm),胞核有4~16叶,胞质内先出现许多交织成网的分隔小管,将胞质分隔成许多小区,每一小区脱落就成为一个血小板。每个巨核细胞平均能生成约 2000个血小板。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条